Hamburg-based biotech Infinite Roots bags €53 million Series B to mushroom up production

Published on January 25, 2024

Infinite Roots, formerly Mushlabs, a leading German biotech company, announced the closing of its €53 million Series B funding round. The oversubscribed funding round represents the largest investment in mycelium technologies in Europe to date and underlines the growing importance of mycelium in the global food system.  It was led by Dr. Hans Riegel Holding…

This content is for members only. Visit the site and log in/register to read.

The post Hamburg-based biotech Infinite Roots bags €53 million Series B to mushroom up production appeared first on EU-Startups.